Dr. Barbra de Vrijer MD
Dr. de Vrijer completed her medical school, residency and fellowship in Maternal Fetal Medicine in The Netherlands and a research fellowship at the University of Colorado Health Sciences Centre in Colorado, USA. In 2006, she joined the Division of Maternal Fetal Medicine at the University of Western Ontario, where she, together with Dr. Penava, established the ‘MY’ Clinic, a specialized clinic for pregnant women with obesity. She has been Head of the Maternal Fetal Medicine Division since May 2017.
Dr. de Vrijer's research focuses on the abnormal uterine environment and its effects on the fetus, with an emphasis on the adverse effects of maternal obesity. With the multidisciplinary Pregnancy Research Group, she specializes in imaging of fetal and placental metabolic health, markers of inflammation, and the microbiome in pregnancies with obesity. Dr. de Vrijer holds a CIHR/SOGC MFM Team grant together with Co-Principal Investigator Dr. Eastabrook and co-investigators Drs. Han, Lala, McKenzie, Penava, Regnault, Shepherd and Siu, and is a co-investigator on a NIH Human Placenta Project grant to develop novel imaging technologies to non-invasively assess placental and fetal metabolism.
I have a relationship with a for-profit and/or a not-for-profit organization to disclose:
- Funded grants or clinical trials: CIHR (not-for-profit, grant), Children's Health Foundation (not-for-profit, grant)
I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).